Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Byrne

Showing results (51-60 of 392) with videos related to

Pageof 40
Sort By:
Diabetes & Metabolism|December 23, 2023
Steatotic liver disease, MASLD and risk of chronic kidney diseaseJosh Bilson, Alessandro Mantovani, Christopher D Byrne, et al.
Current Opinion in Cardiology|May 19, 2012
Nonalcoholic fatty liver disease and vascular riskLokpal S Bhatia, Nicholas P Curzen, Christopher D Byrne
Metabolism: Clinical and Experimental|March 24, 2007
Long-chain n-3 fatty acid supplementation in men increases resistance to activated protein CNicola A Englyst, Robert F Grimble, Christopher D Byrne
Postgraduate Medical Journal|May 16, 2019
Diagnosis and management of non-alcoholic fatty liver diseaseErica Jennison, Janisha Patel, Eleonora Scorletti, et al.
Nucleic Acids Research|February 28, 2002
A novel medium throughput quantitative competitive PCR technology to simultaneously measure mRNA levels from multiple genesJunlong Zhang, Ian N M Day, Christopher D Byrne
The Journal of Clinical Endocrinology and Metabolism|July 23, 2013
Resolution of fatty liver and risk of incident diabetesKi-Chul Sung, Sarah H Wild, Christopher D Byrne
Atherosclerosis|November 26, 2013
Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosisKi-Chul Sung, Sarah H Wild, Christopher D Byrne
Current Opinion in Endocrinology, Diabetes, and Obesity|January 19, 2017
The HDL cholesterol/apolipoprotein A-I ratio: an indicator of cardiovascular diseaseEun-Jung Rhee, Christopher D Byrne, Ki-Chul Sung
Diabetes Care|January 24, 2018
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysisAlessandro Mantovani, Christopher D Byrne, Enzo Bonora, et al.
Journal of Hepatology|January 22, 2014
Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertensionKi-Chul Sung, Sarah H Wild, Christopher D Byrne
Pageof 40

Showing results (51-60 of 392) with videos related to

Sort By:
Pageof 40
Diabetes & Metabolism|December 23, 2023
Steatotic liver disease, MASLD and risk of chronic kidney diseaseJosh Bilson, Alessandro Mantovani, Christopher D Byrne, et al.
Current Opinion in Cardiology|May 19, 2012
Nonalcoholic fatty liver disease and vascular riskLokpal S Bhatia, Nicholas P Curzen, Christopher D Byrne
Metabolism: Clinical and Experimental|March 24, 2007
Long-chain n-3 fatty acid supplementation in men increases resistance to activated protein CNicola A Englyst, Robert F Grimble, Christopher D Byrne
Postgraduate Medical Journal|May 16, 2019
Diagnosis and management of non-alcoholic fatty liver diseaseErica Jennison, Janisha Patel, Eleonora Scorletti, et al.
Nucleic Acids Research|February 28, 2002
A novel medium throughput quantitative competitive PCR technology to simultaneously measure mRNA levels from multiple genesJunlong Zhang, Ian N M Day, Christopher D Byrne
The Journal of Clinical Endocrinology and Metabolism|July 23, 2013
Resolution of fatty liver and risk of incident diabetesKi-Chul Sung, Sarah H Wild, Christopher D Byrne
Atherosclerosis|November 26, 2013
Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosisKi-Chul Sung, Sarah H Wild, Christopher D Byrne
Current Opinion in Endocrinology, Diabetes, and Obesity|January 19, 2017
The HDL cholesterol/apolipoprotein A-I ratio: an indicator of cardiovascular diseaseEun-Jung Rhee, Christopher D Byrne, Ki-Chul Sung
Diabetes Care|January 24, 2018
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysisAlessandro Mantovani, Christopher D Byrne, Enzo Bonora, et al.
Journal of Hepatology|January 22, 2014
Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertensionKi-Chul Sung, Sarah H Wild, Christopher D Byrne
Pageof 40